Effectiveness of tDCS on Reducing Craving in Patients Practicing Chemsex: a Single-center, Double-blind, Randomized Controlled Pilot Trial

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 29, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Chemsex
Interventions
DEVICE

tDCS

"* 1 session/day for 5 consecutive days~* stimulation at an intensity of 2 mA for the active tDCS group and sham stimulation (using the device's sham mode) for the placebo group"

BEHAVIORAL

Assessment of risk behaviours

Assessment of risk behaviours (retrospective exploration by the categorical rating of frequency: At least once a day - Several times a week several times a week - once a week - several times a month - once a month - less than once a month - never). times a month - Once a month - Less than once a month - Never)

OTHER

Scales

EVA craving index for chemsex Maximum VAS craving in the week preceding assessment for chemsex, sexual practices and use of psychoactive substances, HAqII, CSBD-19, modified CCQ-brief, SDI, BDI-II

Trial Locations (1)

Unknown

RECRUITING

CHU Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER